BARONCIANI, LUCIANO
BARONCIANI, LUCIANO
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Challenges and considerations of genetic testing in von Willebrand disease
2025 O. Seidizadeh, L. Baronciani, F. Peyvandi
von Willebrand disease
2024 O. Seidizadeh, J.C.J. Eikenboom, C.V. Denis, V.H. Flood, P. James, P.J. Lenting, L. Baronciani, J.S. O'Donnell, D. Lillicrap, F. Peyvandi
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
2024 O. Seidizadeh, L. Mollica, S. Zambarbieri, L. Baronciani, A. Cairo, P. Colpani, G. Cozzi, M.T. Pagliari, A. Ciavarella, S.M. Siboni, F. Peyvandi
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review
2024 A.C. Giuffrida, S.M. Siboni, L. Baronciani, G. Poli, G. Gandini, F. Peyvandi
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, P. Colpani, G. Cozzi, A. Ciavarella, S.M. Siboni, F. Peyvandi
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
2023 M.T. Pagliari, U. Budde, L. Baronciani, P. Eshghi, M. Ahmadinejad, Z. Badiee, M. Baghaipour, O. Benítez Hidalgo, E. Biguzzi, I. Bodó, G. Castaman, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, P.M. Mannucci, A.B. Federici, J. Eikenboom, F. Peyvandi
Erratum to ‘A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays.’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 3, March 2023, 100139]
2023 P. Colpani, L. Baronciani, F. Stufano, G. Cozzi, M. Boscarino, M.T. Pagliari, E. Biguzzi, F. Peyvandi
Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
2023 P. Colpani, L. Baronciani, G. Cozzi, M.T. Pagliari, E. Biguzzi, F. Peyvandi
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
2022 M.T. Pagliari, F.R. Rosendaal, M. Ahmadinejad, Z. Badiee, M. Baghaipour, L. Baronciani, O. Benítez Hidalgo, I. Bodó, U. Budde, G. Castaman, P. Eshghi, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, P.M. Mannucci, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, F. Peyvandi, A.B. Federici, J. Eikenboom
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
2022 M.T. Pagliari, L. Baronciani, C. Cordiglieri, P. Colpani, G. Cozzi, S.M. Siboni, F. Peyvandi
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease : REPLY from original authors Biguzzi et al
2021 E. Biguzzi, S.M. Siboni, S. le Cessie, L. Baronciani, F.R. Rosendaal, A. van Hylckama Vlieg, F. Peyvandi
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
2021 L. Baronciani, I. Peake, R. Schneppenheim, A. Goodeve, M. Ahmadinejad, Z. Badiee, M.-. Baghaipour, O. Benitez, I. Bodo, U. Budde, A. Cairo, G. Castaman, P. Eshghi, J. Goudemand, W. Hassenpflug, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F.L. Fernandez, P.M. Mannucci, R. Marino, N. Niksic, F. Oyen, C. Santoro, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, E.M.K. Zetterberg, J. Eikenboom, A.B. Federici, F. Peyvandi
Pulmonary tumour thrombotic microangiopathy in a young man: clinical and immunohistochemical characterisation of a rare complication of gastric signet-ring cell carcinoma
2021 R. Rossio, E. Pagliaro, A. Artoni, L. Baronciani, R. Russo, M.C. Mocellin, G. Lopez, F. Peyvandi
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers
2020 A. Szederjesi, L. Baronciani, U. Budde, G. Castaman, P. Colpani, A.S. Lawrie, Y. Liu, R. Montgomery, F. Peyvandi, R. Schneppenheim, J. Patzke, I. Bodó
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
2020 F. Stufano, L. Baronciani, P. Bucciarelli, M. Boscarino, P. Colpani, M.T. Pagliari, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
Bleeding symptoms in patients diagnosed as type 3 Von Willebrand Disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study
2020 A. Tosetto, Z. Badiee, M. Baghaipour, L. Baronciani, J. Battle, E. Berntorp, I. Bodó, U. Budde, G. Castaman, J.C.J. Eikenboom, P. Eshghi, C. Ettorre, A. Goodeve, J. Goudemand, H. Charles Richard Morris, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, P.M. Mannucci, M.G. Mazzucconi, M. Morfini, J. Oldenburg, I. Peake, R. Parra Lòpez, F. Peyvandi, R. Schneppenheim, A. Tiede, G. Toogeh, M. Trossaert, O. Zekavat, E.M.K. Zetterberg, A.B. Federici
How we make an accurate diagnosis of von Willebrand disease
2019 L. Baronciani, F. Peyvandi
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
2019 F. Stufano, M. Boscarino, P. Bucciarelli, L. Baronciani, A. Maino, G. Cozzi, F. Peyvandi